BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 870009)

  • 1. Management of hyperprolactinaemic amenorrhoea.
    Franks S; Jacobs HS; Hull MG; Steele SJ; Nabarro JD
    Br J Obstet Gynaecol; 1977 Apr; 84(4):241-53. PubMed ID: 870009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine treatment of seven women with primary amenorrhoea and prolactin-secreting pituitary tumours.
    Bergh T; Nillius SJ; Wide L
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):145-54. PubMed ID: 570900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine treatment of 42 hyperprolactinaemic women with secondary amenorrhoea.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):435-51. PubMed ID: 354299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactinomas presenting as primary amenorrhoea and delayed or arrested puberty: response to medical therapy.
    Howlett TA; Wass JA; Grossman A; Plowman PN; Charlesworth M; Touzel R; Rees LH; Savage MO; Besser GM
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):131-40. PubMed ID: 2612015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and significance of hyperprolactinaemia in women with amenorrhea.
    Franks S; Murray MA; Jequier AM; Steele SJ; Nabarro JD; Jacobs HS
    Clin Endocrinol (Oxf); 1975 Nov; 4(6):597-607. PubMed ID: 1104218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bromocriptine-induced pregnancy on prolactin-secreting pituitary tumours.
    Bergh T; Nillius SJ; Larsson SG; Wide L
    Acta Endocrinol (Copenh); 1981 Nov; 98(3):333-8. PubMed ID: 7293665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine.
    Nillius SJ; Bergh T; Lundberg PO; Stahle J; Wide L
    Fertil Steril; 1978 Dec; 30(6):710-2. PubMed ID: 729834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine treatment of hyperprolactinaemic hypogonadism.
    Thorner MO; Besser GM
    Acta Endocrinol Suppl (Copenh); 1978; 216():131-46. PubMed ID: 347858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menstrual function and serum prolactin levels after long-term bromocriptine treatment of hyperprolactinaemic amenorrhoea.
    Bergh T; Nillius SJ; Wide L
    Clin Endocrinol (Oxf); 1982 Jun; 16(6):587-93. PubMed ID: 7105430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amenorrhoea and hyperprolactinaemia (author's transl)].
    Tscherne G
    Wien Klin Wochenschr; 1979 Dec; 91(23):790-3. PubMed ID: 538933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pregnancy and lactation on pituitary prolactin-secreting tumours.
    Zárate A; Canales ES; Alger M; Forsbach G
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):407-12. PubMed ID: 517046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including pre-operative bromocriptine therapy.
    Bevan JS; Adams CB; Burke CW; Morton KE; Molyneux AJ; Moore RA; Esiri MM
    Clin Endocrinol (Oxf); 1987 May; 26(5):541-56. PubMed ID: 3665118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinaemia in men-response to bromocriptine therapy.
    Prescott RW; Johnston DG; Kendall-Taylor P; Crombie A; Hall K; McGregor A; Hall R
    Lancet; 1982 Jan; 1(8266):245-8. PubMed ID: 6120274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dilemma of mild hyperprolactinaemia.
    Pepperell RJ; Martinez C; Dickinson A
    Aust N Z J Obstet Gynaecol; 1984 May; 24(2):117-20. PubMed ID: 6594127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative management of pituitary prolactinomas; evidence for bromocriptine-induced regression.
    Hancock KW; Scott JS; Lamb JT; Gibson RM; Chapman C
    Br J Obstet Gynaecol; 1980 Jun; 87(6):523-9. PubMed ID: 7397087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of pregnancies on prolactinomas.
    Rjosk HK; Fahlbusch R; von Werder K
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):337-46. PubMed ID: 7113602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperprolactinaemia in amenorrhoea - incidence and clinical significance.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):683-94. PubMed ID: 335758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperprolactinaemia: its physiology and investigation.
    Judd SJ; Lazarus L; Compton P
    Med J Aust; 1976 Jul; 2(1):23-5. PubMed ID: 988468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of new diagnostic methods on the differential diagnosis and treatment of secondary amenorrhoea.
    Shearman RP; Fraser IS
    Lancet; 1977 Jun; 1(8023):1195-7. PubMed ID: 68286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid regression of pituitary tumours during bromocriptine treatment of women with hyperprolactinaemia.
    Bergh T; Nillius SJ; Lundberg PO; Moström U; Enoksson P; Ohman L; Wide L
    Ups J Med Sci; 1982; 87(3):259-67. PubMed ID: 7157557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.